Urinary DNA methylation‐based risk stratification model to triage patients for repeat transurethral resection of bladder tumours

Documenti analoghi

• Quality of transurethral resection of bladder tumour documentation: implications for non‐muscle‐invasive bladder cancer risk stratification and management
  di: Abram Botros, et al.
  Pubblicazione: (2024)
• Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
  di: Di Chen, et al.
  Pubblicazione: (2024)
• Plasma cell‐free DNA markers predict occult metastases in patients with resectable pancreatic ductal adenocarcinoma
  di: Jacob E. Till, et al.
  Pubblicazione: (2026)
• Concurrent DNA hypomethylation and epigenomic reprogramming driven by androgen receptor binding in bladder cancer oncogenesis
  di: Yu Xiao, et al.
  Pubblicazione: (2024)
• Comprehensive genomic analysis of molecular residual disease based on circulating tumour DNA in postoperative patients with colorectal cancer
  di: Qingqi Hong, et al.
  Pubblicazione: (2024)